Suppression of hyphal formation and virulence of Candida albicans by natural and synthetic compounds

References

• Abdel-Razek AS, El-Naggar ME, Allam A, Morsy OM, Othman SI. 2020. Microbial natural products in drug discovery. Processes. 8:470. doi:https://doi.org/10.3390/pr8040470
   Web of Science ®Google Scholar
• Abirami G, Alexpandi R, Durgadevi R, Kannappan A, Veera Ravi A. 2020. Inhibitory effect of morin against Candida albicans pathogenicity and virulence factor production: an in vitro and in vivo approaches. Front Microbiol. 11:561298. doi:https://doi.org/10.3389/fmicb.2020.561298
   PubMed Web of Science ®Google Scholar
• Ahmed A, Azim A, Gurjar M, Baronia AK. 2014. Current concepts in combination antibiotic therapy for critically ill patients. Indian J Crit Care Med. 18:310–314. doi:https://doi.org/10.4103/0972-5229.132495
   PubMedGoogle Scholar
• Ali EM, Abdallah BM. 2020. Effective inhibition of candidiasis using an eco-friendly leaf extract of Calotropis gigantea mediated silver nanoparticles. Nanomaterials. 10:422. doi:https://doi.org/10.3390/nano10030422
   Web of Science ®Google Scholar
• Allison DL, Willems HME, Jayatilake JAMS, Bruno VM, Peters BM, Shirtliff ME. 2016. Candida–Bacteria interactions: their impact on human disease. Microbiol Spectr. 4(3):VMBF-0030-2016. doi:https://doi.org/10.1128/microbiolspec.VMBF-0030-2016.
   Google Scholar
• Alvarez FJ, Konopka JB. 2007. Identification of an N-acetylglucosamine transporter that mediates hyphal induction in Candida albicans. Mol Biol Cell. 18:965–975. doi:https://doi.org/10.1091/mbc.e06-10-0931
   PubMed Web of Science ®Google Scholar
• Ambrósio JAR, Pinto B, da Silva BGM, Passos J, Beltrame Junior M, Costa MS, Simioni AR. 2020. BSA nanoparticles loaded-methylene blue for photodynamic antimicrobial chemotherapy (PACT): effect on both growth and biofilm formation by Candida albicans. J Biomater Sci Polym Ed. 31:2182–2198. doi:https://doi.org/10.1080/09205063.2020.1795461
   PubMed Web of Science ®Google Scholar
• Anderson TM, Clay MC, Cioffi AG, Diaz KA, Hisao GS, Tuttle MD, Nieuwkoop AJ, Comellas G, Maryum N, Wang S, et al. 2014. Amphotericin forms an extramembranous and fungicidal sterol sponge. Nat Chem Biol. 10:400–406. doi:https://doi.org/10.1038/nchembio.1496
   PubMed Web of Science ®Google Scholar
• Arachchige NIB, Khan F, Kim YM. 2020. Antimicrobial properties of actively purified secondary metabolites isolated from different marine organisms. Curr Pharm Biotechnol. 22(7):920–944. doi:https://doi.org/10.2174/1389201021666200730144536.
   Web of Science ®Google Scholar
• Bahn Y-S, Staab J, Sundstrom P. 2003. Increased high-affinity phosphodiesterase PDE2 gene expression in germ tubes counteracts CAP1-dependent synthesis of cyclic AMP, limits hypha production and promotes virulence of Candida albicans. Mol Microbiol. 50:391–409. doi:https://doi.org/10.1046/j.1365-2958.2003.03692.x
   PubMed Web of Science ®Google Scholar
• Banerjee M, Thompson DS, Lazzell A, Carlisle PL, Pierce C, Monteagudo C, López-Ribot JL, Kadosh D. 2008. UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence. Mol Biol Cell. 19:1354–1365. doi:https://doi.org/10.1091/mbc.e07-11-1110
   PubMed Web of Science ®Google Scholar
• Barriuso J, Hogan DA, Keshavarz T, Martínez MJ. 2018. Role of quorum sensing and chemical communication in fungal biotechnology and pathogenesis. FEMS Microbiol Rev. 42:627–638. doi:https://doi.org/10.1093/femsre/fuy022
   PubMed Web of Science ®Google Scholar
• Barwell KJ, Boysen JH, Xu W, Mitchell AP. 2005. Relationship of DFG16 to the Rim101p pH response pathway in Saccharomyces cerevisiae and Candida albicans. Eukaryot Cell. 4:890–899. doi:https://doi.org/10.1128/EC.4.5.890-899.2005
   PubMedGoogle Scholar
• Beema Shafreen R, Seema S, Martinez-Ayala AL, Lozano-Grande MA, Robles-Sánchez M, Szterk A, Grishko M, Hanuka E, Katrich E, Gorinstein S. 2019. Binding and potential antibiofilm activities of Amaranthus proteins against Candida albicans. Colloids Surf B Biointerfaces. 183:110479. doi:https://doi.org/10.1016/j.colsurfb.2019.110479
   PubMed Web of Science ®Google Scholar
• Belmadani A, Semlali A, Rouabhia M. 2018. Dermaseptin-S1 decreases Candida albicans growth, biofilm formation and the expression of hyphal wall protein 1 and aspartic protease genes. J Appl Microbiol. 125:72–83. doi:https://doi.org/10.1111/jam.13745
   PubMed Web of Science ®Google Scholar
• Benedict K, Jackson BR, Chiller T, Beer KD. 2019. Estimation of direct healthcare costs of fungal diseases in the United States. Clin Infect Dis. 68:1791–1797. doi:https://doi.org/10.1093/cid/ciy776
   PubMed Web of Science ®Google Scholar
• Bérdy J. 2005. Bioactive microbial metabolites. J Antibiot (Tokyo). 58:1–26. doi:https://doi.org/10.1038/ja.2005.1
   PubMed Web of Science ®Google Scholar
• Berman J. 2006. Morphogenesis and cell cycle progression in Candida albicans. Curr Opin Microbiol. 9:595–601. doi:https://doi.org/10.1016/j.mib.2006.10.007
   PubMed Web of Science ®Google Scholar
• Bernard C, Girardot M, Imbert C. 2020. Candida albicans interaction with Gram-positive bacteria within interkingdom biofilms. J Mycol Med. 30:100909. doi:https://doi.org/10.1016/j.mycmed.2019.100909
   PubMed Web of Science ®Google Scholar
• Biswas K, Morschhäuser J. 2005. The Mep2p ammonium permease controls nitrogen starvation-induced filamentous growth in Candida albicans. Mol Microbiol. 56:649–669. doi:https://doi.org/10.1111/j.1365-2958.2005.04576.x
   PubMed Web of Science ®Google Scholar
• Biswas S, Van Dijck P, Datta A. 2007. Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev. 71:348–376. doi:https://doi.org/10.1128/MMBR.00009-06
   PubMed Web of Science ®Google Scholar
• Bockmühl DP, Ernst JF. 2001. A potential phosphorylation site for an A-type kinase in the Efg1 regulator protein contributes to hyphal morphogenesis of Candida albicans. Genetics. 157:1523–1530.
   PubMed Web of Science ®Google Scholar
• Braun BR, Johnson AD. 1997. Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science. 277:105–109. doi:https://doi.org/10.1126/science.277.5322.105
   PubMed Web of Science ®Google Scholar
• Braun BR, Kadosh D, Johnson AD. 2001. NRG1, a repressor of filamentous growth in C.albicans, is down-regulated during filament induction. Embo J. 20:4753–4761. doi:https://doi.org/10.1093/emboj/20.17.4753
   PubMed Web of Science ®Google Scholar
• Brown DH, Jr., Giusani AD, Chen X, Kumamoto CA. 1999. Filamentous growth of Candida albicans in response to physical environmental cues and its regulation by the unique CZF1 gene. Mol Microbiol. 34:651–662. doi:https://doi.org/10.1046/j.1365-2958.1999.01619.x
   PubMed Web of Science ®Google Scholar
• Bruno D, Bartelli TF, Rodrigues CR, Briones MRS. 2018. Prolonged growth of Candida albicans reveals co-isolated bacteria from single yeast colonies. Infect Genet Evol. 65:117–126. doi:https://doi.org/10.1016/j.meegid.2018.07.021
   PubMed Web of Science ®Google Scholar
• Buda De Cesare G, Cristy SA, Garsin DA, Lorenz MC. 2020. Antimicrobial peptides: a new frontier in antifungal therapy. mBio. 11:e02123-20. doi:https://doi.org/10.1128/mBio.02123-20
   PubMed Web of Science ®Google Scholar
• Carlisle PL, Kadosh D. 2010. Candida albicans Ume6, a filament-specific transcriptional regulator, directs hyphal growth via a pathway involving Hgc1 cyclin-related protein. Eukaryot Cell. 9:1320–1328. doi:https://doi.org/10.1128/EC.00046-10
   PubMedGoogle Scholar
• Carlson E. 1982. Synergistic effect of Candida albicans and Staphylococcus aureus on mouse mortality. Infect Immun. 38:921–924. doi:https://doi.org/10.1128/iai.38.3.921-924.1982
   PubMed Web of Science ®Google Scholar
• Carolus H, Van Dyck K, Van Dijck P. 2019. Candida albicans and Staphylococcus species: a threatening twosome [Mini Review]. Front Microbiol. 10:2162. doi:https://doi.org/10.3389/fmicb.2019.02162
   PubMed Web of Science ®Google Scholar
• Cavalheiro M, Teixeira MC. 2018. Candida biofilms: threats, challenges, and promising strategies [Review]. Front Med (Lausanne). 5:28. doi:https://doi.org/10.3389/fmed.2018.00028
   PubMed Web of Science ®Google Scholar
• Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 183:5385–5394. doi:https://doi.org/10.1128/JB.183.18.5385-5394.2001
   PubMed Web of Science ®Google Scholar
• Chang W, Li Y, Zhang L, Cheng A, Lou H. 2012. Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production. PLoS One. 7:e41624. doi:https://doi.org/10.1371/journal.pone.0041624
   PubMed Web of Science ®Google Scholar
• Chen H, Zhou X, Ren B, Cheng L. 2020. The regulation of hyphae growth in Candida albicans. Virulence. 11:337–348. doi:https://doi.org/10.1080/21505594.2020.1748930
   PubMed Web of Science ®Google Scholar
• Cowan MM. 1999. Plant products as antimicrobial agents. Clin Microbiol Rev. 12:564–582. doi:https://doi.org/10.1128/CMR.12.4.564
   PubMed Web of Science ®Google Scholar
• Curvelo JAR, Marques AM, Barreto ALS, Romanos MTV, Portela MB, Kaplan MAC, Soares RMA. 2014. A novel nerolidol-rich essential oil from Piper claussenianum modulates Candida albicans biofilm. J Med Microbiol. 63:697–702. doi:https://doi.org/10.1099/jmm.0.063834-0
   PubMed Web of Science ®Google Scholar
• Davis D, Edwards JE, Jr., Mitchell AP, Ibrahim AS. 2000a. Candida albicans RIM101 pH response pathway is required for host-pathogen interactions. Infect Immun. 68:5953–5959. doi:https://doi.org/10.1128/IAI.68.10.5953-5959.2000
   PubMed Web of Science ®Google Scholar
• Davis D, Wilson RB, Mitchell AP. 2000b. RIM101-dependent and-independent pathways govern pH responses in Candida albicans. Mol Cell Biol. 20:971–978. doi:https://doi.org/10.1128/MCB.20.3.971-978.2000
   PubMed Web of Science ®Google Scholar
• Demain AL, Sanchez S. 2009. Microbial drug discovery: 80 years of progress. J Antibiot (Tokyo). 62:5–16. doi:https://doi.org/10.1038/ja.2008.16
   PubMed Web of Science ®Google Scholar
• Dhillon NK, Sharma S, Khuller GK. 2003. Signaling through protein kinases and transcriptional regulators in Candida albicans. Crit Rev Microbiol. 29:259–275. doi:https://doi.org/10.1080/713610451
   PubMed Web of Science ®Google Scholar
• Diaz PI, Xie Z, Sobue T, Thompson A, Biyikoglu B, Ricker A, Ikonomou L, Dongari-Bagtzoglou A. 2012. Synergistic interaction between Candida albicans and commensal oral streptococci in a novel in vitro mucosal model. Infect Immun. 80:620–632. doi:https://doi.org/10.1128/IAI.05896-11
   PubMed Web of Science ®Google Scholar
• do Nascimento Dias J, de Souza Silva C, de Araújo AR, Souza JMT, de Holanda Veloso Júnior PH, Cabral WF, da Glória da Silva M, Eaton P, de Souza de Almeida Leite JR, Nicola AM, et al. 2020. Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells. Sci Rep. 10:10327. doi:https://doi.org/10.1038/s41598-020-67041-2
   PubMed Web of Science ®Google Scholar
• Douglas LJ. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11:30–36. doi:https://doi.org/10.1016/s0966-842x(02)00002-1
   PubMed Web of Science ®Google Scholar
• Fang J-Y, Tang K-W, Yang S-H, Alalaiwe A, Yang Y-C, Tseng C-H, Yang S-C. 2020. Synthetic naphthofuranquinone derivatives are effective in eliminating drug-resistant Candida albicans in hyphal, biofilm, and intracellular forms: an Application for Skin-Infection Treatment [Original Research]. Front Microbiol. 11:2053. doi:https://doi.org/10.3389/fmicb.2020.02053
   PubMed Web of Science ®Google Scholar
• Fazly A, Jain C, Dehner AC, Issi L, Lilly EA, Ali A, Cao H, Fidel PL, P. Rao R, Kaufman PD. 2013. Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis. Proc Natl Acad Sci U S A. 110:13594–13599. doi:https://doi.org/10.1073/pnas.1305982110
   PubMed Web of Science ®Google Scholar
• Feldman M, Al-Quntar A, Polacheck I, Friedman M, Steinberg D. 2014. Therapeutic potential of thiazolidinedione-8 as an antibiofilm agent against Candida albicans. PLoS One. 9:e93225. doi:https://doi.org/10.1371/journal.pone.0093225
   PubMed Web of Science ®Google Scholar
• Feng Q, Summers E, Guo B, Fink G. 1999. Ras signaling is required for serum-induced hyphal differentiation in Candida albicans. J Bacteriol. 181:6339–6346. doi:https://doi.org/10.1128/JB.181.20.6339-6346.1999
   PubMed Web of Science ®Google Scholar
• Fischbach MA, Walsh CT. 2009. Antibiotics for emerging pathogens. Science. 325:1089–1093. doi:https://doi.org/10.1126/science.1176667
   PubMed Web of Science ®Google Scholar
• Fleming A. 1980. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. Rev Infect Dis. 2:129–139.
   PubMedGoogle Scholar
• Gao M, Wang H, Zhu L. 2016. Quercetin assists fluconazole to inhibit biofilm formations of fluconazole-resistant Candida albicans in in vitro and in vivo antifungal managements of vulvovaginal candidiasis. Cell Physiol Biochem. 40:727–742. doi:https://doi.org/10.1159/000453134
   PubMedGoogle Scholar
• García C, Tebbji F, Daigneault M, Liu NN, Köhler JR, Allen-Vercoe E, Sellam A. 2017. The human gut microbial metabolome modulates fungal growth via the TOR signaling pathway. mSphere. 2:e00555–17. doi:https://doi.org/10.1128/mSphere.00555-17
   PubMed Web of Science ®Google Scholar
• Giusani AD, Vinces M, Kumamoto CA. 2002. Invasive filamentous growth of Candida albicans is promoted by Czf1p-dependent relief of Efg1p-mediated repression. Genetics. 160:1749–1753.
   PubMed Web of Science ®Google Scholar
• Grahl N, Demers EG, Lindsay AK, Harty CE, Willger SD, Piispanen AE, Hogan DA. 2015. Mitochondrial activity and Cyr1 are key regulators of Ras1 activation of C. albicans virulence pathways. PLoS Pathog. 11:e1005133. doi:https://doi.org/10.1371/journal.ppat.1005133
   PubMed Web of Science ®Google Scholar
• Guinan J, Villa P, Thangamani S. 2018. Secondary bile acids inhibit Candida albicans growth and morphogenesis. Pathog Dis. 76(3). doi:https://doi.org/10.1093/femspd/fty038
   Google Scholar
• Gulati M, Nobile CJ. 2016. Candida albicans biofilms: development, regulation, and molecular mechanisms. Microbes Infect. 18:310–321. doi:https://doi.org/10.1016/j.micinf.2016.01.002
   PubMed Web of Science ®Google Scholar
• Gupta P, Goel A, Singh KR, Meher MK, Gulati K, Poluri KM. 2021. Dissecting the anti-biofilm potency of kappa-carrageenan capped silver nanoparticles against Candida species. Int J Biol Macromol. 172:30–40. doi:https://doi.org/10.1016/j.ijbiomac.2021.01.035
   PubMed Web of Science ®Google Scholar
• Gutierrez D, Weinstock A, Antharam VC, Gu H, Jasbi P, Shi X, Dirks B, Krajmalnik-Brown R, Maldonado J, Guinan J, et al. 2020. Antibiotic-induced gut metabolome and microbiome alterations increase the susceptibility to Candida albicans colonization in the gastrointestinal tract. FEMS Microbiol Ecol. 96:fiz187.
   PubMed Web of Science ®Google Scholar
• Halbandge SD, Jadhav AK, Jangid PM, Shelar AV, Patil RH, Karuppayil SM. 2019. Molecular targets of biofabricated silver nanoparticles in Candida albicans. J Antibiot (Tokyo). 72:640–644. doi:https://doi.org/10.1038/s41429-019-0185-9
   PubMed Web of Science ®Google Scholar
• Haque F, Alfatah M, Ganesan K, Bhattacharyya MS. 2016. Inhibitory effect of sophorolipid on Candida albicans biofilm formation and hyphal growth. Sci Rep. 6:23575. doi:https://doi.org/10.1038/srep23575
   PubMed Web of Science ®Google Scholar
• Hasim S, Coleman JJ. 2019. Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents. Future Med Chem. 11:869–883. doi:https://doi.org/10.4155/fmc-2018-0465
   PubMed Web of Science ®Google Scholar
• Hsu C-C, Lai W-L, Chuang K-C, Lee M-H, Tsai Y-C. 2013. The inhibitory activity of linalool against the filamentous growth and biofilm formation in Candida albicans. Med Mycol. 51:473–482. doi:https://doi.org/10.3109/13693786.2012.743051
   PubMed Web of Science ®Google Scholar
• Huang G, Huang Q, Wei Y, Wang Y, Du H. 2019. Multiple roles and diverse regulation of the Ras/cAMP/protein kinase A pathway in Candida albicans. Mol Microbiol. 111:6–16. doi:https://doi.org/10.1111/mmi.14148
   PubMed Web of Science ®Google Scholar
• Iadnut A, Mamoon K, Thammasit P, Pawichai S, Tima S, Preechasuth K, Kaewkod T, Tragoolpua Y, Tragoolpua K. 2019. In Vitro antifungal and antivirulence activities of biologically synthesized ethanolic extract of propolis-loaded PLGA nanoparticles against Candida albicans. Evid Based Complement Alternat Med. 2019:3715481. doi:https://doi.org/10.1155/2019/3715481
   PubMed Web of Science ®Google Scholar
• Jalal M, Ansari MA, Ali SG, Khan HM, Rehman S. 2018. Anticandidal activity of bioinspired ZnO NPs: effect on growth, cell morphology and key virulence attributes of Candida species. Artif Cells Nanomed Biotechnol. 46:912–925. doi:https://doi.org/10.1080/21691401.2018.1439837
   PubMed Web of Science ®Google Scholar
• Jalal M, Ansari MA, Alzohairy MA, Ali SG, Khan HM, Almatroudi A, Siddiqui MI. 2019. Anticandidal activity of biosynthesized silver nanoparticles: effect on growth, cell morphology, and key virulence attributes of Candida species. Int J Nanomed. 14:4667–4679. doi:https://doi.org/10.2147/IJN.S210449
   PubMed Web of Science ®Google Scholar
• Janeczko M, Masłyk M, Kubiński K, Golczyk H. 2017. Emodin, a natural inhibitor of protein kinase CK2, suppresses growth, hyphal development, and biofilm formation of Candida albicans. Yeast. 34:253–265. doi:https://doi.org/10.1002/yea.3230
   PubMed Web of Science ®Google Scholar
• Kadosh D, Lopez-Ribot JL. 2013. Candida albicans: adapting to succeed. Cell Host Microbe. 14:483–485. doi:https://doi.org/10.1016/j.chom.2013.10.016
   PubMed Web of Science ®Google Scholar
• Kagan S, Jabbour A, Sionov E, Alquntar AA, Steinberg D, Srebnik M, Nir-Paz R, Weiss A, Polacheck I. 2014. Anti-candida albicans biofilm effect of novel heterocyclic compounds. J Antimicrob Chemother. 69:416–427. doi:https://doi.org/10.1093/jac/dkt365
   PubMed Web of Science ®Google Scholar
• Kathiravan MK, Salake AB, Chothe AS, Dudhe PB, Watode RP, Mukta MS, Gadhwe S. 2012. The biology and chemistry of antifungal agents: a review. Bioorg Med Chem. 20:5678–5698. doi:https://doi.org/10.1016/j.bmc.2012.04.045
   PubMed Web of Science ®Google Scholar
• Katz L, Baltz RH. 2016. Natural product discovery: past, present, and future. J Ind Microbiol Biotechnol. 43:155–176. doi:https://doi.org/10.1007/s10295-015-1723-5
   PubMed Web of Science ®Google Scholar
• Khan AU, Khan M, Khan MM. 2019. Antifungal and antibacterial assay by silver nanoparticles synthesized from aqueous leaf extract of Trigonella foenum-graecum. BioNanoSci. 9:597–602. doi:https://doi.org/10.1007/s12668-019-00643-x
   Web of Science ®Google Scholar
• Khan F, Bamunuarachchi NI, Pham DTN, Tabassum N, Khan MSA, Kim YM. 2021. Mixed biofilms of pathogenic Candida-bacteria: regulation mechanisms and treatment strategies. Crit Rev Microbiol. 1–29. doi:https://doi.org/10.1080/1040841X.2021.1921696
   Google Scholar
• Khan I, Saeed K, Khan I. 2019. Nanoparticles: properties, applications and toxicities. Arab J Chem. 12:908–931. doi:https://doi.org/10.1016/j.arabjc.2017.05.011
   Web of Science ®Google Scholar
• Kim Y-G, Lee J-H, Park JG, Lee J. 2020. Inhibition of Candida albicans and Staphylococcus aureus biofilms by centipede oil and linoleic acid. Biofouling. 36:126–137. doi:https://doi.org/10.1080/08927014.2020.1730333
   PubMed Web of Science ®Google Scholar
• Klotz SA, Chasin BS, Powell B, Gaur NK, Lipke PN. 2007. Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn Microbiol Infect Dis. 59:401–406. doi:https://doi.org/10.1016/j.diagmicrobio.2007.07.001
   PubMed Web of Science ®Google Scholar
• Kojic EM, Darouiche RO. 2004. Candida infections of medical devices. Clin Microbiol Rev. 17:255–267. doi:https://doi.org/10.1128/CMR.17.2.255-267.2004
   PubMed Web of Science ®Google Scholar
• Koo H, Andes DR, Krysan DJ. 2018. Candida-streptococcal interactions in biofilm-associated oral diseases. PLoS Pathog. 14:e1007342. doi:https://doi.org/10.1371/journal.ppat.1007342
   PubMed Web of Science ®Google Scholar
• Kornitzer D. 2019. Regulation of Candida albicans hyphal morphogenesis by endogenous signals. JoF. 5:21. doi:https://doi.org/10.3390/jof5010021
   Google Scholar
• Krasowska A, Murzyn A, Dyjankiewicz A, Łukaszewicz M, Dziadkowiec D. 2009. The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation. FEMS Yeast Res. 9:1312–1321. doi:https://doi.org/10.1111/j.1567-1364.2009.00559.x
   PubMed Web of Science ®Google Scholar
• Ksiezopolska E, Gabaldón T. 2018. Evolutionary emergence of drug resistance in Candida opportunistic pathogens. Genes (Basel). 9:461. doi:https://doi.org/10.3390/genes9090461
   PubMed Web of Science ®Google Scholar
• Kubiliene L, Laugaliene V, Pavilonis A, Maruska A, Majiene D, Barcauskaite K, Kubilius R, Kasparaviciene G, Savickas A. 2015. Alternative preparation of propolis extracts: comparison of their composition and biological activities. BMC Complement Altern Med. 15:156. doi:https://doi.org/10.1186/s12906-015-0677-5
   PubMed Web of Science ®Google Scholar
• Leach MD, Farrer RA, Tan K, Miao Z, Walker LA, Cuomo CA, Wheeler RT, Brown AJ, Wong KH, Cowen LE. 2016. Hsf1 and Hsp90 orchestrate temperature-dependent global transcriptional remodelling and chromatin architecture in Candida albicans. Nat Commun. 7:11704. doi:https://doi.org/10.1038/ncomms11704
   PubMed Web of Science ®Google Scholar
• Lee J-H, Kim Y-G, Choi P, Ham J, Park JG, Lee J. 2018a. Antibiofilm and antivirulence activities of 6-gingerol and 6-shogaol against Candida albicans due to hyphal inhibition. Front Cell Infect Microbiol. 8:299. doi:https://doi.org/10.3389/fcimb.2018.00299
   PubMed Web of Science ®Google Scholar
• Lee J-H, Kim Y-G, Lee J. 2018b. Inhibition of Candida albicans biofilm and hyphae formation by biocompatible oligomers. Lett Appl Microbiol. 67:123–129. doi:https://doi.org/10.1111/lam.13016
   PubMed Web of Science ®Google Scholar
• Lee J-H, Kim Y-G, Gupta VK, Manoharan RK, Lee J. 2018c. Suppression of fluconazole resistant Candida albicans biofilm formation and filamentation by methylindole derivatives. Front Microbiol. 9:2641. doi:https://doi.org/10.3389/fmicb.2018.02641
   PubMed Web of Science ®Google Scholar
• Lee J-H, Kim Y-G, Khadke SK, Lee J. 2020. Antibiofilm and antifungal activities of medium-chain fatty acids against Candida albicans via mimicking of the quorum-sensing molecule farnesol. Microb Biotechnol. doi:https://doi.org/10.1111/1751-7915.13710
   Google Scholar
• Lee J-H, Kim Y-G, Khadke SK, Yamano A, Watanabe A, Lee J. 2019a. Inhibition of biofilm formation by Candida albicans and polymicrobial microorganisms by nepodin via hyphal-growth suppression. ACS Infect Dis. 5:1177–1187. doi:https://doi.org/10.1021/acsinfecdis.9b00033
   PubMed Web of Science ®Google Scholar
• Lee J-H, Kim Y-G, Khadke SK, Yamano A, Woo J-T, Lee J. 2019b. Antimicrobial and antibiofilm activities of prenylated flavanones from Macaranga tanarius. Phytomedicine. 63:153033. doi:https://doi.org/10.1016/j.phymed.2019.153033
   PubMed Web of Science ®Google Scholar
• Lee JH, Wood TK, Lee J. 2015. Roles of indole as an interspecies and interkingdom signaling molecule. Trends Microbiol. 23:707–718. doi:https://doi.org/10.1016/j.tim.2015.08.001
   PubMed Web of Science ®Google Scholar
• Lee Y, Puumala E, Robbins N, Cowen LE. 2021. Antifungal drug resistance: molecular mechanisms in Candida albicans and beyond. Chem Rev. 121:3390–3411. doi:https://doi.org/10.1021/acs.chemrev.0c00199
   PubMed Web of Science ®Google Scholar
• Letscher-Bru V, Herbrecht R. 2003. Caspofungin: the first representative of a new antifungal class. J Antimicrob Chemother. 51:513–521. doi:https://doi.org/10.1093/jac/dkg117
   PubMed Web of Science ®Google Scholar
• Li B, Webster TJ. 2018. Bacteria antibiotic resistance: new challenges and opportunities for implant-associated orthopedic infections. J Orthop Res. 36:22–32. doi:https://doi.org/10.1002/jor.23656
   PubMed Web of Science ®Google Scholar
• Li D-D, Zhao L-X, Mylonakis E, Hu G-H, Zou Y, Huang T-K, Yan L, Wang Y, Jiang Y-Y. 2014. In vitro and in vivo activities of pterostilbene against Candida albicans biofilms. Antimicrob Agents Chemother. 58:2344–2355. doi:https://doi.org/10.1128/AAC.01583-13
   PubMed Web of Science ®Google Scholar
• Li Y, Chang W, Zhang M, Ying Z, Lou H. 2015. Natural product solasodine-3-O-β-D-glucopyranoside inhibits the virulence factors of Candida albicans. FEMS Yeast Res. 15:fov060. doi:https://doi.org/10.1093/femsyr/fov060
   PubMed Web of Science ®Google Scholar
• Li Y, Shan M, Li S, Wang Y, Yang H, Chen Y, Gu B, Zhu Z. 2020. Teasaponin suppresses Candida albicans filamentation by reducing the level of intracellular cAMP. Ann Transl Med. 8:175. doi:https://doi.org/10.21037/atm.2020.01.124
   PubMed Web of Science ®Google Scholar
• Li Y, Shan M, Yan M, Yao H, Wang Y, Gu B, Zhu Z, Li H. 2019. Anticandidal activity of kalopanaxsaponin A: effect on proliferation, cell morphology, and key virulence attributes of Candida albicans. Front Microbiol. 10:2844. doi:https://doi.org/10.3389/fmicb.2019.02844
   PubMed Web of Science ®Google Scholar
• Lin M-Y, Yuan Z-L, Hu D-D, Hu G-H, Zhang R-L, Zhong H, Yan L, Jiang Y-Y, Su J, Wang Y. 2019. Effect of loureirin A against Candida albicans biofilms. Chin J Nat Med. 17:616–623. doi:https://doi.org/10.1016/S1875-5364(19)30064-0
   PubMed Web of Science ®Google Scholar
• Liu H, Köhler J, Fink GR. 1994. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science. 266:1723–1726. doi:https://doi.org/10.1126/science.7992058
   PubMed Web of Science ®Google Scholar
• Liu N, Zhong H, Tu J, Jiang Z, Jiang Y, Jiang Y, Jiang Y, Li J, Zhang W, Wang Y, et al. 2018. Discovery of simplified sampangine derivatives as novel fungal biofilm inhibitors. Eur J Med Chem. 143:1510–1523. doi:https://doi.org/10.1016/j.ejmech.2017.10.043
   PubMed Web of Science ®Google Scholar
• Liu R-H, Shang Z-C, Li T-X, Yang M-H, Kong L-Y. 2017. In vitro antibiofilm activity of eucarobustol E against Candida albicans. Antimicrob Agents Chemother. 61:e02707-16. doi:https://doi.org/10.1128/AAC.02707-16
   PubMed Web of Science ®Google Scholar
• Madariaga-Venegas F, Fernández-Soto R, Duarte LF, Suarez N, Delgadillo D, Jara JA, Fernández-Ramires R, Urzúa B, Molina-Berríos A. 2017. Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients. PLoS One. 12:e0176755. doi:https://doi.org/10.1371/journal.pone.0176755
   PubMed Web of Science ®Google Scholar
• Manoharan RK, Lee J-H, Kim Y-G, Kim S-I, Lee J. 2017. Inhibitory effects of the essential oils α-longipinene and linalool on biofilm formation and hyphal growth of Candida albicans. Biofouling. 33:143–155. doi:https://doi.org/10.1080/08927014.2017.1280731
   PubMed Web of Science ®Google Scholar
• Manoharan RK, Lee JH, Kim YG, Lee J. 2017a. Alizarin and chrysazin inhibit biofilm and hyphal formation by Candida albicans. Front Cell Infect Microbiol. 7:447. doi:https://doi.org/10.3389/fcimb.2017.00447
   PubMed Web of Science ®Google Scholar
• Manoharan RK, Lee J-H, Lee J. 2017b. Antibiofilm and antihyphal activities of cedar leaf essential oil, camphor, and fenchone derivatives against Candida albicans. Front Microbiol. 8:1476. doi:https://doi.org/10.3389/fmicb.2017.01476
   PubMed Web of Science ®Google Scholar
• Manoharan RK, Lee JH, Lee J. 2018. Efficacy of 7-benzyloxyindole and other halogenated indoles to inhibit Candida albicans biofilm and hyphal formation. Microb Biotechnol. 11:1060–1069. doi:https://doi.org/10.1111/1751-7915.13268
   PubMed Web of Science ®Google Scholar
• Mayer FL, Wilson D, Hube B. 2013. Candida albicans pathogenicity mechanisms. Virulence. 4:119–128. doi:https://doi.org/10.4161/viru.22913
   PubMed Web of Science ®Google Scholar
• Mazzoli R, Riedel K, Pessione E. 2017. Editorial: Bioactive compounds from microbes. Front Microbiol. 8:392. doi:https://doi.org/10.3389/fmicb.2017.00392
   PubMed Web of Science ®Google Scholar
• McDonough KA, Rodriguez A. 2011. The myriad roles of cyclic AMP in microbial pathogens: from signal to sword. Nat Rev Microbiol. 10:27–38. doi:https://doi.org/10.1038/nrmicro2688
   PubMed Web of Science ®Google Scholar
• Meng L, Zhao H, Zhao S, Sun X, Zhang M, Deng Y. 2019. Inhibition of yeast-to-hypha transition and virulence of Candida albicans by 2-alkylaminoquinoline derivatives. Antimicrob Agents Chemother. 63:e01891-18. doi:https://doi.org/10.1128/AAC.01891-18
   PubMed Web of Science ®Google Scholar
• Messier C, Epifano F, Genovese S, Grenier D. 2011. Inhibition of Candida albicans biofilm formation and yeast-hyphal transition by 4-hydroxycordoin. Phytomedicine. 18:380–383. doi:https://doi.org/10.1016/j.phymed.2011.01.013
   PubMed Web of Science ®Google Scholar
• Messier C, Grenier D. 2011. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. Mycoses. 54:e801–e806. doi:https://doi.org/10.1111/j.1439-0507.2011.02028.x
   PubMed Web of Science ®Google Scholar
• Montelongo-Jauregui D, Srinivasan A, Ramasubramanian AK, Lopez-Ribot JL. 2018. An In vitro model for Candida albicans, Streptococcus gordonii biofilms on titanium surfaces. J Fungi (Basel). 4(2):66. doi:https://doi.org/10.3390/jof4020066.
   Google Scholar
• Mukaremera L, Lee KK, Mora-Montes HM, Gow NAR. 2017. Candida albicans yeast, pseudohyphal, and hyphal morphogenesis differentially affects immune recognition. Front Immunol. 8:629. doi:https://doi.org/10.3389/fimmu.2017.00629
   PubMed Web of Science ®Google Scholar
• Müller K, Bugnicourt E, Latorre M, Jorda M, Echegoyen Sanz Y, Lagaron JM, Miesbauer O, Bianchin A, Hankin S, Bölz U, et al. 2017. Review on the processing and properties of polymer nanocomposites and nanocoatings and their applications in the packaging, automotive and solar energy fields. Nanomaterials. 7(4):74. doi:https://doi.org/10.3390/nano7040074
   Google Scholar
• Murad AM, Leng P, Straffon M, Wishart J, Macaskill S, MacCallum D, Schnell N, Talibi D, Marechal D, Tekaia F, et al. 2001. NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. Embo J. 20:4742–4752. doi:https://doi.org/10.1093/emboj/20.17.4742
   PubMed Web of Science ®Google Scholar
• Murzyn A, Krasowska A, Stefanowicz P, Dziadkowiec D, Łukaszewicz M. 2010. Capric acid secreted by S. boulardii Inhibits C. albicans filamentous growth, adhesion and biofilm formation. PLoS One. 5:e12050. doi:https://doi.org/10.1371/journal.pone.0012050
   PubMed Web of Science ®Google Scholar
• Muthamil S, Balasubramaniam B, Balamurugan K, Pandian SK. 2018. Synergistic effect of quinic acid derived from Syzygium cumini and undecanoic acid against Candida spp. Biofilm and Virulence. Front Microbiol. 9:2835–2835. doi:https://doi.org/10.3389/fmicb.2018.02835
   PubMed Web of Science ®Google Scholar
• Muthamil S, Prasath KG, Priya A, Precilla P, Pandian SK. 2020. Global proteomic analysis deciphers the mechanism of action of plant derived oleic acid against Candida albicans virulence and biofilm formation. Sci Rep. 10(1):5113. doi:https://doi.org/10.1038/s41598-020-61918-y
   PubMed Web of Science ®Google Scholar
• Neelabh, Singh K, Rani J. 2016. Sequential and structural aspects of antifungal peptides from animals, bacteria and fungi based on bioinformatics tools. Probiotics Antimicrob Proteins. 8:85–101. doi:https://doi.org/10.1007/s12602-016-9212-3
   PubMed Web of Science ®Google Scholar
• Nile C, Falleni M, Cirasola D, Alghamdi A, Anderson OF, Delaney C, Ramage G, Ottaviano E, Tosi D, Bulfamante G, et al. 2019. Repurposing pilocarpine hydrochloride for treatment of Candida albicans infections. mSphere. 4:e00689-18. doi:https://doi.org/10.1128/mSphere.00689-18
   PubMed Web of Science ®Google Scholar
• Nithyanand P, Beema Shafreen RM, Muthamil S, Karutha Pandian S. 2015. Usnic acid inhibits biofilm formation and virulent morphological traits of Candida albicans. Microbiol Res. 179:20–28. doi:https://doi.org/10.1016/j.micres.2015.06.009
   PubMed Web of Science ®Google Scholar
• Nobile CJ, Johnson AD. 2015. Candida albicans biofilms and human disease. Annu Rev Microbiol. 69:71–92. doi:https://doi.org/10.1146/annurev-micro-091014-104330
   PubMed Web of Science ®Google Scholar
• Pammi M, Zhong D, Johnson Y, Revell P, Versalovic J. 2014. Polymicrobial bloodstream infections in the neonatal intensive care unit are associated with increased mortality: a case-control study. BMC Infect Dis. 14:390. doi:https://doi.org/10.1186/1471-2334-14-390
   PubMed Web of Science ®Google Scholar
• Papuc C, Goran GV, Predescu CN, Nicorescu V, Stefan G. 2017. Plant polyphenols as antioxidant and antibacterial agents for shelf-life extension of meat and meat products: classification, structures, sources, and action mechanisms. Compr Rev Food Sci Food Saf. 16:1243–1268. doi:https://doi.org/10.1111/1541-4337.12298
   PubMed Web of Science ®Google Scholar
• Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MP, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, et al. 2018. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 16:71. doi:https://doi.org/10.1186/s12951-018-0392-8
   PubMed Web of Science ®Google Scholar
• Pentland DR, Piper-Brown E, Mühlschlegel FA, Gourlay CW. 2017. Ras signalling in pathogenic yeasts. Microb Cell. 5:63–73. doi:https://doi.org/10.15698/mic2018.02.612
   PubMed Web of Science ®Google Scholar
• Perlin DS. 2011. Current perspectives on echinocandin class drugs. Future Microbiol. 6:441–457. doi:https://doi.org/10.2217/fmb.11.19
   PubMed Web of Science ®Google Scholar
• Pierce CG, Chaturvedi AK, Lazzell AL, Powell AT, Saville SP, McHardy SF, Lopez-Ribot JL. 2015. A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance. NPJ Biofilms Microbiomes. 2015;1:15012.:doi:https://doi.org/10.1038/npjbiofilms.2015.12
   Google Scholar
• Pierce JV, Dignard D, Whiteway M, Kumamoto CA. 2013. Normal adaptation of Candida albicans to the murine gastrointestinal tract requires Efg1p-dependent regulation of metabolic and host defense genes. Eukaryot Cell. 12:37–49. doi:https://doi.org/10.1128/EC.00236-12
   PubMed Web of Science ®Google Scholar
• Priya A, Pandian SK. 2020. Piperine impedes biofilm formation and hyphal morphogenesis of Candida albicans. Front Microbiol. 11:756. doi:https://doi.org/10.3389/fmicb.2020.00756
   PubMed Web of Science ®Google Scholar
• Qian W, Zhang J, Wang W, Liu M, Fu Y, Li X, Wang T, Li Y. 2020. Efficacy of chelerythrine against mono- and dual-species biofilms of Candida albicans and Staphylococcus aureus and its properties of inducing hypha-to-yeast transition of C. albicans. JoF. 6:45. doi:https://doi.org/10.3390/jof6020045
   Google Scholar
• Qiao Y-N, Jin X-Y, Zhou J-C, Zhang J-Z, Chang W-Q, Li Y, Chen W, Ren Z-J, Zhang C-Y, Yuan S-Z, et al. 2020. Terpenoids from the Liverwort Plagiochila fruticosa and their antivirulence activity against Candida albicans. J Nat Prod. 83:1766–1777. doi:https://doi.org/10.1021/acs.jnatprod.9b00895
   PubMed Web of Science ®Google Scholar
• Rahman A, Harunsani MH, Tan AL, Khan MM. 2021. Zinc oxide and zinc oxide-based nanostructures: biogenic and phytogenic synthesis, properties and applications. Bioprocess Biosyst Eng. 44:1333–1372. doi:https://doi.org/10.1007/s00449-021-02530-w
   PubMed Web of Science ®Google Scholar
• Rajasekharan SK, Byun J, Lee J. 2018a. Inhibitory effects of deoxynivalenol on pathogenesis of Candida albicans. J Appl Microbiol. 125:1266–1275. doi:https://doi.org/10.1111/jam.14032
   PubMed Web of Science ®Google Scholar
• Rajasekharan SK, Lee JH, Zhao Y, Lee J. 2018b. The mycotoxin zearalenone hinders Candida albicans biofilm formation and hyphal morphogenesis. Indian J Microbiol. 58:19–27. doi:https://doi.org/10.1007/s12088-017-0690-0
   PubMed Web of Science ®Google Scholar
• Rajasekharan SK, Lee J-H, Lee J. 2019. Aripiprazole repurposed as an inhibitor of biofilm formation and sterol biosynthesis in multidrug-resistant Candida albicans. Int J Antimicrob Agents. 54:518–523. doi:https://doi.org/10.1016/j.ijantimicag.2019.05.016
   PubMed Web of Science ®Google Scholar
• Ramage G, Wickes BL, López-Ribot JL. 2007. Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA). Mycopathologia. 164:301–306. doi:https://doi.org/10.1007/s11046-007-9068-x
   PubMed Web of Science ®Google Scholar
• Ramanathan S, Arunachalam K, Chandran S, Selvaraj R, Shunmugiah KP, Arumugam VR. 2018. Biofilm inhibitory efficiency of phytol in combination with cefotaxime against nosocomial pathogen Acinetobacter baumannii. J Appl Microbiol. 125:56–71. doi:https://doi.org/10.1111/jam.13741
   PubMed Web of Science ®Google Scholar
• Ramasamy M, Nanda SS, Lee JH, Lee J. 2020. Construction of alizarin conjugated graphene oxide composites for inhibition of Candida albicans biofilms. Biomolecules. 10:565. doi:https://doi.org/10.3390/biom10040565
   Web of Science ®Google Scholar
• Revie NM, Iyer KR, Robbins N, Cowen LE. 2018. Antifungal drug resistance: evolution, mechanisms and impact. Curr Opin Microbiol. 45:70–76. doi:https://doi.org/10.1016/j.mib.2018.02.005
   PubMed Web of Science ®Google Scholar
• Rezzoagli C, Archetti M, Mignot I, Baumgartner M, Kümmerli R. 2020. Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa. PLoS Biol. 18:e3000805. doi:https://doi.org/10.1371/journal.pbio.3000805
   PubMed Web of Science ®Google Scholar
• Rodrigues ME, Gomes F, Rodrigues CF. 2019. Candida spp./Bacteria mixed biofilms. J Fungi (Basel). 6(1):5. doi:https://doi.org/10.3390/jof6010005
   Google Scholar
• Romo JA, Kumamoto CA. 2020. On commensalism of Candida. JoF. 6:16. doi:https://doi.org/10.3390/jof6010016
   Google Scholar
• Romo JA, Pierce CG, Chaturvedi AK, Lazzell AL, McHardy SF, Saville SP, Lopez-Ribot JL. 2017. Development of anti-virulence approaches for candidiasis via a novel series of small-molecule inhibitors of Candida albicans filamentation. mBio. 8:e01991-17. doi:https://doi.org/10.1128/mBio.01991-17
   PubMed Web of Science ®Google Scholar
• Romo JA, Pierce CG, Esqueda M, Hung C-Y, Saville SP, Lopez-Ribot JL. 2018. In vitro Characterization of a biaryl amide anti-virulence compound targeting Candida albicans filamentation and biofilm formation. Front Cell Infect Microbiol. 8:227. doi:https://doi.org/10.3389/fcimb.2018.00227
   PubMed Web of Science ®Google Scholar
• Różalska B, Sadowska B, Budzyńska A, Bernat P, Różalska S. 2018. Biogenic nanosilver synthesized in Metarhizium robertsii waste mycelium extract - As a modulator of Candida albicans morphogenesis, membrane lipidome and biofilm. PLoS One. 13:e0194254. doi:https://doi.org/10.1371/journal.pone.0194254
   PubMed Web of Science ®Google Scholar
• Sautour M, Mitaine-Offer A, Miyamoto T, Dongmo A, Lacaille-Dubois M. 2004. Antifungal steroid saponins from Dioscorea cayenensis. Planta Med. 70:90–92. doi:https://doi.org/10.1055/s-2004-815467
   PubMed Web of Science ®Google Scholar
• Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. 2003. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell. 2:1053–1060. doi:https://doi.org/10.1128/EC.2.5.1053-1060.2003
   PubMed Web of Science ®Google Scholar
• Shapiro RS, Robbins N, Cowen LE. 2011. Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol Mol Biol Rev. 75:213–267. doi:https://doi.org/10.1128/MMBR.00045-10
   PubMed Web of Science ®Google Scholar
• Shapiro RS, Uppuluri P, Zaas AK, Collins C, Senn H, Perfect JR, Heitman J, Cowen LE. 2009. Hsp90 orchestrates temperature-dependent Candida albicans morphogenesis via Ras1-PKA signaling. Curr Biol. 19:621–629. doi:https://doi.org/10.1016/j.cub.2009.03.017
   PubMed Web of Science ®Google Scholar
• Sharma D, Kanchi S, Bisetty K. 2019. Biogenic synthesis of nanoparticles: a review. Arab J Chem. 12:3576–3600. doi:https://doi.org/10.1016/j.arabjc.2015.11.002
   Web of Science ®Google Scholar
• Shrivash MK, Mishra S, Panwar SL, Sircaik S, Pandey J, Misra K. 2018. Attenuation of pathogenicity in Candida albicans by application of polyphenols. J Microb Biochem Technol. 10:27–39. doi:https://doi.org/10.4172/1948-5948.1000392
   Google Scholar
• Silva S, Rodrigues CF, Araújo D, Rodrigues ME, Henriques M. 2017. Candida species biofilms' antifungal resistance. JoF. 3:8. doi:https://doi.org/10.3390/jof3010008
   Web of Science ®Google Scholar
• Singh R, Kumar M, Mittal A, Mehta PK. 2017. Microbial metabolites in nutrition, healthcare and agriculture. 3 Biotech. 7:15. doi:https://doi.org/10.1007/s13205-016-0586-4
   PubMedGoogle Scholar
• Stoldt VR, Sonneborn A, Leuker CE, Ernst JF. 1997. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. Embo J. 16:1982–1991. doi:https://doi.org/10.1093/emboj/16.8.1982
   PubMed Web of Science ®Google Scholar
• Subramenium GA, Swetha TK, Iyer PM, Balamurugan K, Pandian SK. 2018. 5-hydroxymethyl-2-furaldehyde from marine bacterium Bacillus subtilis inhibits biofilm and virulence of Candida albicans. Microbiol Res. 207:19–32. doi:https://doi.org/10.1016/j.micres.2017.11.002
   PubMed Web of Science ®Google Scholar
• Sun L, Liao K, Wang D. 2015. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans. PLoS One. 10:e0117695. doi:https://doi.org/10.1371/journal.pone.0117695
   PubMed Web of Science ®Google Scholar
• Taff HT, Mitchell KF, Edward JA, Andes DR. 2013. Mechanisms of Candida biofilm drug resistance. Future Microbiol. 8:1325–1337. doi:https://doi.org/10.2217/fmb.13.101
   PubMed Web of Science ®Google Scholar
• Takó M, Kerekes EB, Zambrano C, Kotogán A, Papp T, Krisch J, Vágvölgyi C. 2020. Plant phenolics and phenolic-enriched extracts as antimicrobial agents against food-contaminating microorganisms. Antioxidants (Basel). 9:165. doi:https://doi.org/10.3390/antiox9020165
   Google Scholar
• Thompson DS, Carlisle PL, Kadosh D. 2011. Coevolution of morphology and virulence in Candida species. Eukaryot Cell. 10:1173–1182. doi:https://doi.org/10.1128/EC.05085-11
   PubMed Web of Science ®Google Scholar
• Tsang PW-K, Bandara HMHN, Fong W-P. 2012. Purpurin suppresses Candida albicans biofilm formation and hyphal development. PLoS One. 7:e50866. doi:https://doi.org/10.1371/journal.pone.0050866
   PubMed Web of Science ®Google Scholar
• Tsui C, Kong EF, Jabra-Rizk MA. 2016. Pathogenesis of Candida albicans biofilm. Pathog Dis. 74:ftw018. doi:https://doi.org/10.1093/femspd/ftw018
   PubMed Web of Science ®Google Scholar
• Uppuluri P, Chaturvedi AK, Srinivasan A, Banerjee M, Ramasubramaniam AK, Köhler JR, Kadosh D, Lopez-Ribot JL. 2010. Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog. 6:e1000828. doi:https://doi.org/10.1371/journal.ppat.1000828
   PubMed Web of Science ®Google Scholar
• Venkata S, Zeeshan F, Kamal A, Luqman AK, Saif H. 2020. Efficiency of vanillin in impeding metabolic adaptability and virulence of Candida albicans by inhibiting glyoxylate cycle, morphogenesis, and biofilm formation. Curr Med Mycol. 6:1–8. doi:https://doi.org/10.18502/cmm.6.1.2501
   PubMedGoogle Scholar
• Villa S, Hamideh M, Weinstock A, Qasim MN, Hazbun TR, Sellam A, Hernday AD, Thangamani S. 2020. Transcriptional control of hyphal morphogenesis in Candida albicans. FEMS Yeast Res. 20:foaa005.
   PubMed Web of Science ®Google Scholar
• Vinces MD, Haas C, Kumamoto CA. 2006. Expression of the Candida albicans morphogenesis regulator gene CZF1 and its regulation by Efg1p and Czf1p. Eukaryot Cell. 5:825–835. doi:https://doi.org/10.1128/EC.5.5.825-835.2006
   PubMedGoogle Scholar
• Wagh VD. 2013. Propolis: a wonder bees product and its pharmacological potentials. Adv Pharmacol Sci. 2013:308249. doi:https://doi.org/10.1155/2013/308249
   PubMedGoogle Scholar
• Wang X, You J, King JB, Powell DR, Cichewicz RH. 2012. Waikialoid A suppresses hyphal morphogenesis and inhibits biofilm development in pathogenic Candida albicans. J Nat Prod. 75:707–715. doi:https://doi.org/10.1021/np2009994
   PubMed Web of Science ®Google Scholar
• Wijesinghe GK, Maia FC, de Oliveira TR, de Feiria SNB, Joia F, Barbosa JP, Boni GC, Sardi JCO, Rosalen PL, Höfling JF. 2020. Effect of Cinnamomum verum leaf essential oil on virulence factors of Candida species and determination of the in-vivo toxicity with Galleria mellonella model. Mem Inst Oswaldo Cruz. 115:e200349. doi:https://doi.org/10.1590/0074-02760200349
   PubMed Web of Science ®Google Scholar
• Xu K, Wang JL, Chu MP, Jia C. 2019. Activity of coumarin against Candida albicans biofilms. J Mycol Med. 29:28–34. doi:https://doi.org/10.1016/j.mycmed.2018.12.003
   PubMed Web of Science ®Google Scholar
• Yan Y, Tan F, Miao H, Wang H, Cao Y. 2019. Effect of shikonin against Candida albicans biofilms. Front Microbiol. 10:1085. doi:https://doi.org/10.3389/fmicb.2019.01085
   PubMed Web of Science ®Google Scholar
• Yang L, Liu X, Sui Y, Ma Z, Feng X, Wang F, Ma T. 2019a. Lycorine hydrochloride inhibits the virulence traits of Candida albicans. Biomed Res Int. 2019:1851740. doi:https://doi.org/10.1155/2019/1851740
   PubMed Web of Science ®Google Scholar
• Yang L, Liu X, Zhong L, Sui Y, Quan G, Huang Y, Wang F, Ma T. 2018. Dioscin inhibits virulence factors of Candida albicans. Biomed Res Int. 2018:4651726. doi:https://doi.org/10.1155/2018/4651726
   PubMed Web of Science ®Google Scholar
• Yang L, Ren S, Xu F, Ma Z, Liu X, Wang L. 2019b. Recent advances in the pharmacological activities of dioscin. Biomed Res Int. 2019:5763602. doi:https://doi.org/10.1155/2019/5763602
   PubMed Web of Science ®Google Scholar
• Yang LF, Liu X, Lv LL, Ma ZM, Feng XC, Ma TH. 2018. Dracorhodin perchlorate inhibits biofilm formation and virulence factors of Candida albicans. J Mycol Med. 28:36–44. doi:https://doi.org/10.1016/j.mycmed.2017.12.011
   PubMed Web of Science ®Google Scholar
• Ying L, Mingzhu S, Mingju Y, Ye X, Yuechen W, Ying C, Bing G, Hongchun L, Zuobin Z. 2019. The inhibition of trans-cinnamaldehyde on the virulence of Candida albicans via enhancing farnesol secretion with low potential for the development of resistance. Biochem Biophys Res Commun. 515:544–550. doi:https://doi.org/10.1016/j.bbrc.2019.05.165
   PubMed Web of Science ®Google Scholar
• Yuan H, Ma Q, Ye L, Piao G. 2016. The traditional medicine and modern medicine from natural products. Molecules. 21:559. doi:https://doi.org/10.3390/molecules21050559
   PubMed Web of Science ®Google Scholar
• Zeidler U, Lettner T, Lassnig C, Müller M, Lajko R, Hintner H, Breitenbach M, Bito A. 2009. UME6 is a crucial downstream target of other transcriptional regulators of true hyphal development in Candida albicans. FEMS Yeast Res. 9:126–142. doi:https://doi.org/10.1111/j.1567-1364.2008.00459.x
   PubMed Web of Science ®Google Scholar
• Zeng B, Li J, Wang Y, Chen P, Wang X, Cui J, Liu L, Hu X, Cao Q, Xiao Y, et al. 2017. In vitro and in vivo effects of suloctidil on growth and biofilm formation of the opportunistic fungus Candida albicans. Oncotarget. 8:69972–69982. doi:https://doi.org/10.18632/oncotarget.19542
   PubMedGoogle Scholar
• Zhang M, Chang W, Shi H, Zhou Y, Zheng S, Li Y, Li L, Lou H. 2017. Biatriosporin D displays anti-virulence activity through decreasing the intracellular cAMP levels. Toxicol Appl Pharmacol. 322:104–112. doi:https://doi.org/10.1016/j.taap.2017.03.004
   PubMed Web of Science ®Google Scholar
• Zhao LX, Li DD, Hu DD, Hu GH, Yan L, Wang Y, Jiang YY. 2013. Effect of tetrandrine against Candida albicans biofilms. PLoS One. 8:e79671. doi:https://doi.org/10.1371/journal.pone.0079671
   PubMed Web of Science ®Google Scholar
• Zheng X, Wang Y, Wang Y. 2004. Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J. 23:1845–1856. doi:https://doi.org/10.1038/sj.emboj.7600195
   PubMed Web of Science ®Google Scholar
• Zhong H, Hu D-D, Hu G-H, Su J, Bi S, Zhang Z-E, Wang Z, Zhang R-L, Xu Z, Jiang Y-Y, et al. 2017. Activity of sanguinarine against Candida albicans biofilms. Antimicrob Agents Chemother. 61:e02259-16. doi:https://doi.org/10.1128/AAC.02259-16
   PubMed Web of Science ®Google Scholar